A detailed history of Evergreen Capital Management LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Evergreen Capital Management LLC holds 12,754 shares of INVA stock, worth $241,050. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,754
Previous 12,321 3.51%
Holding current value
$241,050
Previous $202,000 21.78%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.33 - $20.04 $7,070 - $8,677
433 Added 3.51%
12,754 $246,000
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $17,409 - $19,827
1,209 Added 10.88%
12,321 $202,000
Q4 2023

Feb 14, 2024

BUY
$12.32 - $16.27 $2,365 - $3,123
192 Added 1.76%
11,112 $178,000
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $5,554 - $6,236
-449 Reduced 3.95%
10,920 $141,000
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $129,492 - $155,982
11,369 New
11,369 $144,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.